On March 21, 2024, Dr. Xiaohu (Tiger) Xie, was a featured speaker at the National Center for Advancing Translational Science (NCATS) and Georgia Clinical & Translational Science Alliance (CTSA’s) Small Business Funding Webinar. Dr. Xie’s extensive background offered an insightful perspective on the NIH Applicant Assistance Program (AAP) and the preparation of SBIR/STTR applications. Researchers […]
Read More →
On January 24, Dr. Eva Garland joins Justina W. Gallegos, Deputy Director, White House Office of Science and Technology Policy; Maya Goodwin, Senior Advisor, Workforce and Economic Opportunity Policy, Department of Energy; and Leah Garden, Climate Tech Reporter at @GreenBiz, for a Women+ in Climate Tech Global Network discussion exploring how government funds can be […]
Read More →
EGC is pleased to sponsor the Redefining Early Stage Investments (RESI) Conference at the JP Morgan Conference in San Francisco on January 9, 2024. We are excited to meet with current and future clients to implement strategies for accessing government funding to advance cutting edge health care technologies in 2024!
Read More →
On October 5-6, 2023, the EGC Team will be attending BioVenture Nexus located at the JW Marriott-The Ritz Carlton Los Angeles, CA. BioVenture Nexus is the premier event for innovation and networking in the Synthetic Biology, Biotech Industry, Life Science, Food Tech, and AI in Biology. Scientific Grants Expert, Dr. Chelcie Heaney, will be presenting […]
Read More →
Eva Garland Consulting, LLC (EGC) is excited once again to be named as one of the fastest growing privately owned companies in the United States by capturing a spot on the Inc. 5000 list for the sixth consecutive year. We are extremely grateful for our of 55 employees and 2500+ Clients for contributing to the […]
Read More →
Eva Garland Consulting (EGC) is thrilled to extend our partnership with the National Institutes of Health (NIH) to support small businesses in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP). Currently in its 5th year, the AAP has supported over 500 companies in submitting NIH SBIR/STTR applications that have resulted in over $34 […]
Read More →
On Monday, June 26, at 1:00 p.m. ET., Dr. Xiaohu (Tiger) Xie, a Scientific Grants Expert from Eva Garland Consulting, will present a talk titled “Application Tips & Resources to Help Secure SBIR & STTR Funding”, sponsored by the NIH’s National Center for Advancing Translation Science (NCATS).
Read More →
EGC is pleased to announce that our CEO, Dr. Eva Garland, is moderating a panel titled “Executing My Award” at the SBIR/STTR Spring Innovation Conference in Washington, DC on June 21, 2023. Dr. Garland is joined by experts in the field of SBIR/STTR award management, including Eric Blatt, Brian LaCroix, and John Ure.
Read More →
Eva Garland Consulting (EGC) is excited to announce the publication of the 4th edition of our Amazon best-selling book on the NIH SBIR/STTR program. The Small Business Innovation Research (SBIR) program provides non-dilutive funding in the form of grants to help companies commercialize transformative technologies, yet the complex application process can be daunting. This book provides […]
Read More →
Eva Garland Consulting (EGC) is excited to extend our partnership with the National Institutes of Health (NIH) to provide small businesses with FREE support in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP). Now in its 4th year, the AAP has supported over 650 companies in applying for NIH SBIR/STTR applications, resulting in over $39 million […]
Read More →